Table 3.
Variable | Univariatea | Multivariateb | |||
---|---|---|---|---|---|
P-value | HR | 95% CI | P-value | ||
Sex | Male vs. Female | 0.5704 | — | ||
Age | ≥65 vs. <65 | 0.2171 | — | ||
T stage (TNM) | T3-T4 vs. T1-T2 | 0.0306 | 2.06 | 0.52–10.0 | 0.3032 |
N stage (TNM) | N1 vs. N0 | 0.0147 | 1.00 | 0.30–3.26 | 0.9956 |
M stage (TNM) | M1 vs. M0 | 0.0019 | 7.68 | 1.58–30.0 | 0.0149 |
Plasma miR-107 expression | Low vs. High | 0.0038 | 2.95 | 1.03–9.46 | 0.0424 |
aKaplan–Meier method; significance was determined by the log-rank test. bMultivariate survival analysis was performed using Cox’s proportional hazards model. HR: hazard ratio; CI: confidence interval. NOTE: significant values are in bold.